Just six months after raising $150 million in an upsized series E financing, cardiometabolic specialist Carmot Therapeutics has filed for an initial public offe 21 November 2023
GLP-1 agonists are transforming the way cardiometabolic disorders are treated, with new approvals in obesity opening the door to significant new treatment oppor 17 November 2023
Novo Nordisk, one of Denmark’s largest companies, is to invest around $6 billion in the expansion of manufacturing facilities in Kalundborg. 10 November 2023
Eli Lilly has reported strong revenues for the third quarter, with blockbuster diabetes med Mounjaro (tirzepatide) doing much of the heavy lifting. 2 November 2023
Sanofi has presented new data from its Phase III program for Tzield (teplizumab-mzwv) at the 49th Annual ISPAD Conference, in The Netherlands. 18 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.